• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于Catalyst的药物设计中的药效团建模与三维数据库搜索:最新进展

Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.

作者信息

Güner Osman, Clement Omoshile, Kurogi Yasuhisa

机构信息

Accelrys, 9685 Scranton Road, San Diego, CA 92121, USA.

出版信息

Curr Med Chem. 2004 Nov;11(22):2991-3005. doi: 10.2174/0929867043364036.

DOI:10.2174/0929867043364036
PMID:15544485
Abstract

Perceiving a pharmacophore is the first essential step towards understanding the interaction between a receptor and a ligand. Once a pharmacophore is established, a beneficial use of it is 3D database searching to retrieve novel compounds that would match the pharmacophore. As the 3D searching technology has evolved over the years, it has been effectively used for lead optimization, combinatorial library focusing, as well as virtual high-throughput screening. This paper is an update to the original paper published in this journal earlier: Kurogi, Y, and Guner, O. F. "Pharmacophore Modeling and Three-Dimensional Database Searching for Drug Design Using Catalyst," in Current Medicinal Chemistry, 2001, 8(9), 1035-1055.

摘要

识别药效团是理解受体与配体之间相互作用的首要关键步骤。一旦确定了药效团,其一个有益的用途就是进行三维数据库搜索,以检索与药效团匹配的新型化合物。随着三维搜索技术多年来的发展,它已被有效地用于先导优化、组合库聚焦以及虚拟高通量筛选。本文是对该期刊早期发表的原文的更新:黑木洋、古纳·O·F. “使用Catalyst进行药效团建模和三维数据库搜索用于药物设计”,载于《当代药物化学》,2001年,第8卷第9期,第1035 - 1055页。

相似文献

1
Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.基于Catalyst的药物设计中的药效团建模与三维数据库搜索:最新进展
Curr Med Chem. 2004 Nov;11(22):2991-3005. doi: 10.2174/0929867043364036.
2
Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.基于Catalyst的药效团模型构建及三维数据库搜索用于药物设计
Curr Med Chem. 2001 Jul;8(9):1035-55. doi: 10.2174/0929867013372481.
3
Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.人凝血因子Xa抑制剂的药效团识别、计算机筛选及虚拟文库设计
J Chem Inf Model. 2005 Jan-Feb;45(1):146-59. doi: 10.1021/ci049778k.
4
Novel lead generation through hypothetical pharmacophore three-dimensional database searching: discovery of isoflavonoids as nonsteroidal inhibitors of rat 5 alpha-reductase.
J Med Chem. 2001 Nov 8;44(23):3759-63. doi: 10.1021/jm010433s.
5
Use of catalyst pharmacophore models for screening of large combinatorial libraries.使用催化剂药效团模型筛选大型组合文库。
J Chem Inf Comput Sci. 2002 Sep-Oct;42(5):1204-11. doi: 10.1021/ci020368a.
6
Virtual screening: an effective tool for lead structure discovery?
Curr Pharm Des. 2001 May;7(7):509-27. doi: 10.2174/1381612013397861.
7
Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.基于药效团的3D-QSAR建模、虚拟筛选和对接以鉴定β-分泌酶的潜在抑制剂
Comput Biol Chem. 2017 Jun;68:107-117. doi: 10.1016/j.compbiolchem.2017.03.001. Epub 2017 Mar 6.
8
Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.基于相关向量的虚拟筛选中分子比对的模糊药效团模型
J Med Chem. 2004 Sep 9;47(19):4653-64. doi: 10.1021/jm031139y.
9
Use of peptide combinatorial libraries in drug design: the identification of a potent serotonin reuptake inhibitor derived from a tripeptide cassette library.肽组合文库在药物设计中的应用:从三肽盒式文库中鉴定出一种有效的5-羟色胺再摄取抑制剂。
Chem Biol. 1995 Jul;2(7):483-7. doi: 10.1016/1074-5521(95)90265-1.
10
Novel technologies for virtual screening.虚拟筛选的新技术。
Drug Discov Today. 2004 Jan 1;9(1):27-34. doi: 10.1016/S1359-6446(04)02939-3.

引用本文的文献

1
Identification of novel PHGDH inhibitors based on computational investigation: an all-in-one combination strategy to develop potential anti-cancer candidates.基于计算研究鉴定新型磷酸甘油酸脱氢酶(PHGDH)抑制剂:开发潜在抗癌候选物的一体化组合策略
Front Pharmacol. 2024 Aug 27;15:1405350. doi: 10.3389/fphar.2024.1405350. eCollection 2024.
2
Epigenetic targets in B- and T-cell lymphomas: latest developments.B细胞和T细胞淋巴瘤中的表观遗传靶点:最新进展
Ther Adv Hematol. 2023 May 30;14:20406207231173485. doi: 10.1177/20406207231173485. eCollection 2023.
3
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning.
利用基于结构和基于配体的分子建模以及机器学习发现新型强效赖氨酸特异性组蛋白去甲基化酶-1(LSD-1)抑制剂
RSC Adv. 2022 Dec 15;12(55):35873-35895. doi: 10.1039/d2ra05102h. eCollection 2022 Dec 12.
4
In Silico Drug Discovery for Treatment of Virus Diseases.病毒病治疗的计算药物发现。
Adv Exp Med Biol. 2022;1368:73-93. doi: 10.1007/978-981-16-8969-7_4.
5
Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study.利用活性悬崖构建药效团模型并与其他药效团生成方法比较:以鞘氨醇激酶1为例进行研究
J Comput Aided Mol Des. 2022 Jan;36(1):39-62. doi: 10.1007/s10822-021-00435-0. Epub 2022 Jan 21.
6
Development of a Novel Pharmacophore Model Guided by the Ensemble of Waters and Small Molecule Fragments Bound to SARS-CoV-2 Main Protease.基于与 SARS-CoV-2 主蛋白酶结合的水分子和小分子片段的集合指导的新型药效团模型的开发。
Mol Inform. 2022 Feb;41(2):e2100178. doi: 10.1002/minf.202100178. Epub 2021 Oct 11.
7
Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches.通过基于配体和结构的计算方法鉴定 3-((1-(苄基(2-羟基-2-苯乙基)氨基)-1-氧代-3-苯基丙-2-基)氨甲酰基)吡嗪-2-羧酸作为非核苷类逆转录酶抑制剂的潜在抑制剂。
Molecules. 2021 Aug 30;26(17):5262. doi: 10.3390/molecules26175262.
8
Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development:: In Silico Smart Molecular Design.人工智能与诊断和治疗放射性药物开发的未来:计算机辅助智能分子设计。
PET Clin. 2021 Oct;16(4):513-523. doi: 10.1016/j.cpet.2021.06.008. Epub 2021 Aug 5.
9
Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.长链维生素 E 代谢产物的探索:发现一种高效、口服有效且代谢稳定的 5-LOX 抑制剂,可限制炎症。
J Med Chem. 2021 Aug 12;64(15):11496-11526. doi: 10.1021/acs.jmedchem.1c00806. Epub 2021 Jul 19.
10
Hybrid and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors.基于杂交和时间分辨荧光能量共振转移技术指导的新型BCL-2抑制剂的发现
ACS Pharmacol Transl Sci. 2021 Apr 15;4(3):1111-1123. doi: 10.1021/acsptsci.0c00210. eCollection 2021 Jun 11.